MolNFT v1 · #105374 · protein
Crystal structure analysis of PYK2 and paxillin ld motifs
4R32 · Protein-tyrosine kinase 2-beta: “Crystal structure analysis of PYK2 and paxillin ld motifs”. X-ray diffraction. MolNFT v1 #105374 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 4R32
- Type
- protein
- Length
- 158 residues
- Chains
- 3
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Protein-tyrosine kinase 2-beta; Paxillin
- UniProt
- Q14289, P49024
Structure
x-ray diffraction · 3 distinct chains · 86% helix, 0% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Protein-tyrosine kinase 2-beta | protein | 132 | 86% helix, 0% strand | Q14289 |
| B | Paxillin | protein | 11 | 82% helix, 0% strand | P49024 |
| C | Paxillin | protein | 15 | 87% helix, 0% strand | P49024 |
Interfaces
2 interfaces between chains.
- A–C · 538 Ų buried · 4 hydrogen bonds · protein-protein
- A–B · 374 Ų buried · 3 hydrogen bonds · protein-protein
Compared structures
- 4R32 · Crystal Structure Analysis of Pyk2 and Paxillin LD motifs · the same entry in another collection · chain A against A, TM-score 1.00
- Q14289 · AlphaFold monomer V2.0 prediction for protein-tyrosine kinase 2-beta (Q14289) · a predicted model of the same protein · chain A against A, TM-score 0.96
- P49024 · AlphaFold monomer V2.0 prediction for paxillin (P49024) · a predicted model of the same protein · chain C against A, TM-score 0.83
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q14289
- Every structure of UniProt P49024
- Elsewhere: RCSB PDB 4R32 · PDBe 4R32 · UniProt Q14289 · UniProt P49024
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.